Trials / Completed
CompletedNCT02287766
Metabolic Syndrome Feasibility Study
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 193 (actual)
- Sponsor
- Epic Research & Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with Metabolic Syndrome identified by medical doctors.
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-06-01
- Completion
- 2015-08-01
- First posted
- 2014-11-11
- Last updated
- 2015-08-04
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02287766. Inclusion in this directory is not an endorsement.